Organic nanoparticles for drug delivery and imaging

Nanotechnology has had a huge impact on the development of therapeutics over the last couple of decades. To date, a large number of organic nanoparticles have been developed to encapsulate and deliver therapeutic and imaging agents. These nanoparticles have allowed encapsulation and targeted release of drugs. A few nanoparticle-based drugs are already being used in patients, and several others are making excellent progress toward clinical translation. The strong pipeline of therapeutic nanoparticles is fueled by advances in novel materials and design features, new applications, and a better understanding of fundamental hurdles that limit the utility of nanoparticles. The articles in this issue of MRS Bulletin are focused on some of the significant recent advances in the use of organic nanoparticles for drug delivery and imaging.

[1]  Samir Mitragotri,et al.  Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium , 2013, Proceedings of the National Academy of Sciences.

[2]  Samir Mitragotri,et al.  Particle shape enhances specificity of antibody-displaying nanoparticles , 2013, Proceedings of the National Academy of Sciences.

[3]  Peisheng Xu,et al.  pH and redox dual responsive nanoparticle for nuclear targeted drug delivery. , 2012, Molecular pharmaceutics.

[4]  Y. Barenholz.  Doxil®--the first FDA-approved nano-drug: lessons learned. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[5]  A. Chilkoti,et al.  Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake. , 2012, Nano letters.

[6]  Elizabeth Huynh,et al.  Biodegradable star polymers shine for cancer drug delivery. , 2011, Nanomedicine.

[7]  Elizabeth Huynh,et al.  Biodegradable star polymers shine for cancer drug delivery. , 2011, Nanomedicine.

[8]  D. Irvine,et al.  Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.

[9]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[10]  Hiroshi Maeda,et al.  EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy. , 2011, Advanced drug delivery reviews.

[11]  S. Sahoo,et al.  PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. , 2011, Advanced drug delivery reviews.

[12]  J. Lahann,et al.  Compartmentalized photoreactions within compositionally anisotropic Janus microstructures. , 2011, Macromolecular rapid communications.

[13]  Erkki Ruoslahti,et al.  Coadministration of a Tumor-Penetrating Peptide Enhances the Efficacy of Cancer Drugs , 2010, Science.

[14]  Hiroshi Maeda,et al.  Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. , 2010, Bioconjugate chemistry.

[15]  M Ferrari,et al.  Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Samir Mitragotri,et al.  Designer Biomaterials for Nanomedicine , 2009 .

[17]  E. Ruoslahti,et al.  C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration , 2009, Proceedings of the National Academy of Sciences.

[18]  M. S. Muthu,et al.  PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. , 2009, Nanomedicine : nanotechnology, biology, and medicine.

[19]  X. Ye,et al.  Recent advances in biological strategies for targeted drug delivery. , 2009, Cardiovascular & hematological disorders drug targets.

[20]  Samir Mitragotri,et al.  Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[21]  M. Magnani,et al.  New biomimetic constructs for improved in vivo circulation of superparamagnetic nanoparticles. , 2008, Journal of nanoscience and nanotechnology.

[22]  Weibo Cai,et al.  Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy , 2008, Proceedings of the National Academy of Sciences.

[23]  Samir Mitragotri,et al.  Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[24]  S. Mitragotri,et al.  Making polymeric micro- and nanoparticles of complex shapes , 2007, Proceedings of the National Academy of Sciences.

[25]  Samir Mitragotri,et al.  Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.

[26]  V. Torchilin.  Targeted pharmaceutical nanocarriers for cancer therapy and imaging , 2007, The AAPS Journal.

[27]  Stephanie E. A. Gratton,et al.  Imparting size, shape, and composition control of materials for nanomedicine. , 2006, Chemical Society reviews.

[28]  Frank Caruso,et al.  Layer-by-layer engineered capsules and their applications , 2006 .

[29]  T. Ishida,et al.  Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[30]  Xiaoping Hu,et al.  Long‐circulating liposomal contrast agents for magnetic resonance imaging , 2006, Magnetic resonance in medicine.

[31]  Dhananjay Dendukuri,et al.  Continuous-flow lithography for high-throughput microparticle synthesis , 2006, Nature materials.

[32]  J. Richie,et al.  Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Francis C Szoka,et al.  Designing dendrimers for biological applications , 2005, Nature Biotechnology.

[34]  K. Beningo,et al.  Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. , 2002, Journal of cell science.

[35]  S M Moghimi,et al.  Long-circulating and target-specific nanoparticles: theory to practice. , 2001, Pharmacological reviews.

[36]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[37]  R. J. Lee,et al.  Targeted drug delivery via the folate receptor. , 2000, Advanced drug delivery reviews.

[38]  E. Ruoslahti,et al.  Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.

[39]  J. West,et al.  Nanoshells for photothermal cancer therapy. , 2010, Methods in molecular biology.

[40]  Samir Mitragotri,et al.  Physical approaches to biomaterial design. , 2009, Nature materials.